ISMP and CPOE
At a recent blog post, I commented on my thoughts regarding ISMP and the use of their recommended standards. I am now hoping I can get readers to weigh in on a situation I have at my organization. We are preparing for CPOE and in the medication formulary build, the implementation team has recommended that we use ISMP recommendations for the nomenclature in the medication formulary build effort. I know ISMP is not a regulated but a highly recommended standard. To my surprise however, I have received some strong (more like violent 
) push back from our Pharmacy department reporting that ISMP is only a recommendation for drug labels and that even current drugs released today do not even follow the standard.
I understand that currently medication standards are not there yet, but want to engage the organization to look at the future and what standards should be imposed now to prepare for the future.
Our Pharmacy Department has put out a position statement regarding this internal debate we are having (see below):
(I was scribbling my comments over the document and decided to cross them out)
Has anyone tried to pursue this and what has been your experience?
Any feedback greatly appreciated…comments section is open…
Flickr
